For the Quarter Ending June 2026
Metoclopramide HCL Prices in APAC
- In China, the Metoclopramide HCL Price Index rose quarter-over-quarter in Q2 2026, driven by increasing production costs and robust demand.
- Metoclopramide HCL production costs increased due to elevated input prices in June 2026, as PPI rose 4.1% year-over-year.
- In India, the average price of Metoclopramide HCL is 128000/MT USD.
- China's manufacturing sector expanded in June 2026, with industrial production increasing 5.3% year-over-year, boosting Metoclopramide HCL demand.
- Raw material inventories for manufacturing declined in Q2 2026, contributing to upward pressure on Metoclopramide HCL production costs.
- Robust chemical exports from China, including commodity chemicals, surged in Q2 2026, impacting Metoclopramide HCL trade flows.
- Low CPI (1.0%) and retail sales (1.0%) in June 2026, alongside stable unemployment (5.0%), influenced Metoclopramide HCL demand.
- Policy incentives supported the generic drug segment in Q2 2026, maintaining its significant role for Metoclopramide HCL.
Why did the price of Metoclopramide HCL change in June 2026 in APAC?
- Rising production costs, with PPI increasing 4.1% in June 2026, pressured Metoclopramide HCL prices.
- Strong industrial production, up 5.3% in June 2026, indicated robust demand for Metoclopramide HCL.
- Declining raw material inventories in Q2 2026 contributed to higher input prices for Metoclopramide HCL.
Metoclopramide HCL Prices in North America
- In United States, the Metoclopramide HCL Price Index rose quarter-over-quarter in Q2 2026, driven by significant producer-level inflation.
- Metoclopramide HCL production costs increased in Q2 2026, driven by 5.5% PPI and 3.5% CPI year-over-year in June 2026.
- Demand for Metoclopramide HCL saw an upward trend in Q2 2026, supported by climbing U.S. healthcare spending and utilization.
- The Metoclopramide HCL price forecast indicated continued upward pressure due to sustained healthcare utilization in Q2 2026.
- Industrial electricity prices inched up in April 2026, contributing to higher Metoclopramide HCL manufacturing expenses.
- Robust U.S. retail sales, which grew 6.9% year-over-year in May 2026, supported overall healthcare demand.
- A low 4.2% unemployment rate in June 2026 increased healthcare access and demand for prescribed medications.
- Sluggish industrial production (0.7% YoY in June 2026) and moderate consumer confidence (91.2) created demand headwinds.
Why did the price of Metoclopramide HCL change in June 2026 in North America?
- Producer Price Index rose 5.5% year-over-year in June 2026, increasing Metoclopramide HCL raw material costs.
- Overall U.S. healthcare spending continued to climb in Q2 2026, boosting demand for Metoclopramide HCL.
- Industrial electricity prices inched up in April 2026, contributing to higher Metoclopramide HCL manufacturing expenses.
Metoclopramide HCL Prices in Europe
- In Germany, the Metoclopramide HCL Price Index rose quarter-over-quarter in Q2 2026, driven by surging production costs and supply disruptions.
- Metoclopramide HCL production costs increased in Q2 2026, influenced by a 2.2% year-on-year rise in producer prices in May 2026.
- Demand for Metoclopramide HCL was supported by an aging population and chronic diseases in Q2 2026.
- Metoclopramide HCL demand faced headwinds from negative consumer confidence, recorded at -14.6% in June 2026.
- European natural gas prices remained sharply elevated through Q2 2026, increasing Metoclopramide HCL manufacturing expenses.
- Germany's industrial production was unchanged year-on-year in May 2026, indicating stable demand for chemical inputs.
- Precautionary stockpiling temporarily boosted Metoclopramide HCL sales in Germany during Q2 2026.
- The Manufacturing Index in Germany showed a contracting trend in June 2026, impacting the supply chain.
- Retail sales in Germany increased by 1.8% year-on-year in May 2026, supporting healthcare expenditures.
Why did the price of Metoclopramide HCL change in June 2026 in Europe?
- Rising production costs due to 2.2% PPI increase in May 2026 and elevated energy prices.
- Supply disruptions from Middle East conflicts tightened European chemical markets in Q2 2026.
- Consumer price inflation was +2.3% in June 2026, impacting purchasing power.
For the Quarter Ending March 2026
Metoclopramide HCL Prices in North America
- In United States, the Metoclopramide HCL Price Index rose quarter-over-quarter in Q1 2026, driven by elevated chemical production costs.
- During March 2026, CPI rose 3.3% and PPI increased 4.0%, elevating the Metoclopramide HCL Production Cost Trend.
- Retail sales grew 4.0% and unemployment held at 4.3% in March 2026, supporting the Metoclopramide HCL Demand Outlook.
- Industrial production grew 0.7% and consumer confidence reached 91.8 in March 2026, tightening overall Metoclopramide HCL supply.
- The Manufacturing Index expanded in March 2026, reflecting stable production capacity for the Metoclopramide HCL Price Index.
- Crude oil feedstock costs strengthened in March 2026, directly increasing the overall Metoclopramide HCL Production Cost Trend.
- Global chemical supply chains faced disruptions in Q1 2026, while EU trade surpluses diminished in Feb 2026.
- Despite softened downstream demand in Q1 2026, the Metoclopramide HCL Price Forecast pointed upward due to tight inventories.
Why did the price of Metoclopramide HCL change in March 2026 in North America?
- Elevated crude oil feedstock costs in March 2026 directly increased Metoclopramide HCL synthesis expenses significantly.
- A 4.0% producer price increase in March 2026 forced manufacturers to pass costs downstream immediately.
- Global supply chain disruptions throughout Q1 2026 constrained availability, driving up Metoclopramide HCL prices consistently.
Metoclopramide HCL Prices in APAC
- In China, the Metoclopramide HCL Price Index rose quarter-over-quarter in Q1 2026, driven by surging upstream petrochemical feedstock costs.
- The Metoclopramide HCL Production Cost Trend increased in March 2026 as the Producer Price Index rose 0.5%.
- The Metoclopramide HCL Demand Outlook strengthened in March 2026, supported by a 5.7% expansion in industrial production.
- Consumer prices grew 1.0% in March 2026, while retail sales increased 1.7%, maintaining baseline Metoclopramide HCL consumption.
- An unemployment rate of 5.4% in March 2026 and a 91.6 consumer confidence index in February 2026 constrained retail purchases.
- The Manufacturing Index expanded in March 2026, reflecting robust pharmaceutical sector activity and increased Metoclopramide HCL API procurement.
- Brent crude oil and naphtha feedstock costs surged in March 2026 following maritime chokepoint closures, inflating Metoclopramide HCL expenses.
- The Metoclopramide HCL Price Forecast indicated upward pressure in Q1 2026 due to severe shipment delays and elevated freight.
Why did the price of Metoclopramide HCL change in March 2026 in APAC?
- Toluene, naphtha, and methanol precursor costs surged in March 2026 amid severe trade flow disruptions.
- Brent crude oil prices spiked in March 2026 following military engagements and maritime chokepoint closures.
- The Producer Price Index rose 0.5% in March 2026, reflecting higher factory-gate chemical manufacturing costs.
Metoclopramide HCL Prices in Europe
- In Germany, the Metoclopramide HCL Price Index rose quarter-over-quarter in Q1 2026, driven by surging feedstock costs.
- The Metoclopramide HCL Production Cost Trend increased in March 2026 as 2.7% inflation elevated operational expenses.
- Although producer prices declined -0.2% in March 2026, toluene and benzene feedstock costs surged significantly.
- The Manufacturing Index expanded in March 2026, while industrial production remained stagnant at 0.0% in February 2026.
- Retail sales grew 0.7% and unemployment stayed at 4.2% in February 2026, supporting steady pharmaceutical consumption.
- The Metoclopramide HCL Demand Outlook weakened in March 2026 as consumer confidence dropped to a -24.7 index.
- Ammonia precursor costs for Metoclopramide HCL spiked during Q1 2026 amid widespread global supply disruptions.
- Shipping container rates surged in March 2026 as the Strait of Hormuz closure restricted chemical exports.
- The Metoclopramide HCL Price Forecast showed upward pressure in March 2026 due to escalating natural gas costs.
Why did the price of Metoclopramide HCL change in March 2026 in Europe?
- Crude oil and natural gas prices surged in March 2026, inflating chemical production costs significantly.
- European benzene and global ammonia availability tightened in Q1 2026, driving up essential precursor expenses.
- The Strait of Hormuz closure restricted chemical trade flows in March 2026, disrupting regional supply.
For the Quarter Ending December 2025
Metoclopramide HCL Prices in North America
- In the United States, the Metoclopramide HCL Price Index rose quarter-over-quarter in Q4 2025, driven by increasing production costs.
- Consumer Price Index increased 2.7% year-over-year in December 2025, raising raw material and energy costs.
- Producer Price Index climbed 3.0% year-over-year in November 2025, indicating higher input costs for chemical manufacturers.
- Natural gas feedstock costs surged in late 2025 due to a polar vortex, impacting Metoclopramide HCL manufacturing.
- Industrial production increased 2.0% year-over-year in December 2025, supporting the chemical supply chain.
- Retail sales increased 3.3% year-over-year in November 2025, supporting healthcare spending and pharmaceutical demand.
- The pharmaceutical sector experienced a cautious recovery in Q4 2025, with established pharmaceutical sales growing.
- Tariffs on chemical inputs threatened to inflate costs and reshape supply chains during Q4 2025.
Why did the price of Metoclopramide HCL change in December 2025 in North America?
- Rising Producer Price Index (3.0% YoY in November 2025) increased input costs for Metoclopramide HCL production.
- Natural gas feedstock costs surged in late 2025, directly elevating manufacturing expenses for the chemical.
- Increased industrial production (2.0% YoY in December 2025) and growing established pharmaceutical sales supported demand.
Metoclopramide HCL Prices in APAC
- In China, the Metoclopramide HCL Price Index declined in Q4 2025, driven by falling producer prices.
- Metoclopramide HCL production costs decreased in December 2025, as producer prices fell 1.9% year-over-year.
- Demand for Metoclopramide HCL faced pressure in December 2025 due to weak retail sales growth of 0.9%.
- The Manufacturing Index expanded in December 2025, indicating robust industrial activity supporting Metoclopramide HCL supply.
- Industrial production increased 5.2% year-over-year in December 2025, ensuring stable supply for Metoclopramide HCL.
- Consumer sentiment cooled in Q4 2025, contributing to a cautious outlook for Metoclopramide HCL demand.
- Low inflationary pressures, with CPI at 0.8% in December 2025, impacted Metoclopramide HCL manufacturing costs.
- The unemployment rate stood at 5.1% in December 2025, reflecting a stable labor market affecting healthcare spending.
- The Metoclopramide HCL price forecast suggests continued stability or slight declines, given cost and demand dynamics.
Why did the price of Metoclopramide HCL change in December 2025 in APAC?
- Producer prices declined 1.9% in December 2025, reducing Metoclopramide HCL manufacturing costs.
- Weak retail sales growth of 0.9% in December 2025 dampened Metoclopramide HCL demand.
- Expanding manufacturing activity in December 2025 supported robust supply, influencing Metoclopramide HCL prices.
Metoclopramide HCL Prices in Europe
- In Germany, the Metoclopramide HCL Price Index fell quarter-over-quarter in Q4 2025, influenced by declining producer prices.
- Metoclopramide HCL production costs faced mixed pressures; producer prices fell 2.5% year-on-year in December 2025.
- Operational costs for Metoclopramide HCL manufacturers increased as consumer prices rose 1.8% year-on-year in December 2025.
- Metoclopramide HCL demand outlook weakened, with the Manufacturing Index showing a contracting trend in December 2025.
- Consumer confidence remained pessimistic at -17.5 index points in December 2025, impacting healthcare spending.
- Industrial production growth was modest at 0.8% year-on-year in October 2025, indicating limited broader industrial expansion.
- The unemployment rate stood at 6.2% in December 2025, potentially constraining healthcare affordability and public funding.
- The Metoclopramide HCL price trend reflected ongoing economic contraction and mixed cost pressures during Q4 2025.
Why did the price of Metoclopramide HCL change in December 2025 in Europe?
- Producer prices fell 2.5% year-on-year in December 2025, reducing Metoclopramide HCL raw material costs.
- The Manufacturing Index contracted in December 2025, signaling weakened overall economic activity.
- Consumer confidence remained low at -17.5 index points in December 2025, impacting healthcare spending.
For the Quarter Ending September 2025
Metoclopramide HCL Prices in North America
- In United States, the Metoclopramide HCL Price Index rose in Q3 2025, driven by increasing production costs.
- Metoclopramide HCL production costs increased in Q3 2025, influenced by a 2.6% PPI rise in August 2025.
- The Metoclopramide HCL Demand Outlook was supported by a resurgence in the pharmaceutical sector in Q3 2025.
- The Metoclopramide HCL Price Forecast suggests continued upward pressure due to anticipated rising production costs.
- US natural gas prices strengthened throughout Q3 2025, impacting Metoclopramide HCL energy and feedstock expenses.
- A 3.0% CPI increase in September 2025 raised raw material and operational costs for Metoclopramide HCL production.
- A 4.3% unemployment rate in September 2025 supported patient access and affordability for Metoclopramide HCL.
- US chemical industry inventories shrank in Q3 2025, reflecting intensified destocking efforts by manufacturers.
Why did the price of Metoclopramide HCL change in September 2025 in North America?
- Production costs for Metoclopramide HCL increased due to a 2.6% PPI rise in August 2025.
- Rising natural gas prices in Q3 2025 contributed to higher energy and feedstock expenses.
- A 3.0% CPI increase in September 2025 elevated raw material and operational costs.
Metoclopramide HCL Prices in APAC
- In China, the Metoclopramide HCL Price Index fell quarter-over-quarter in Q3 2025, influenced by oversupply and deflationary pressures.
- Metoclopramide HCL production costs declined in September 2025, as producer prices fell 2.3% year-on-year.
- Metoclopramide HCL demand supported by 3.0% retail sales growth and 5.2% unemployment in September 2025.
- The Metoclopramide HCL price forecast indicates continued downward pressure due to broad chemical oversupply in Q3 2025.
- The Manufacturing Index contracted in September 2025, signaling economic slowdown impacting the supply chain.
- Robust pharmaceutical manufacturing growth in 2025, driven by aging population, supports Metoclopramide HCL demand.
- Persistent oversupply in the broader chemical sector in Q3 2025, from capacity additions, impacted market balance.
- General chemical feedstock costs remained steady in Q3 2025, despite ongoing high energy cost concerns.
- China's industrial production increased 6.5% year-on-year in September 2025, supporting the manufacturing base.
Why did the price of Metoclopramide HCL change in September 2025 in APAC?
- CPI fell 0.3% and PPI fell 2.3% in September 2025, exerting downward price pressure.
- Persistent oversupply in the broader chemical sector during Q3 2025, driven by capacity additions.
- Contracting Manufacturing Index and low consumer confidence (89.6) in September 2025 signaled caution.
Metoclopramide HCL Prices in Europe
- In Germany, the Metoclopramide HCL Price Index fell quarter-over-quarter in Q3 2025, influenced by declining producer prices.
- Elevated raw material costs and strengthened industrial electricity, influenced by 2.4% CPI, increased production.
- Producer prices for chemical and pharma declined -1.7% year-over-year in September 2025, easing input costs.
- Metoclopramide HCL demand outlook supported by aging population and increasing chronic diseases.
- German industrial production contracted -1.0% year-over-year in September 2025, impacting raw material.
- The Manufacturing Index contracted in Q3 2025, signaling a slowdown across German manufacturing.
- A low unemployment rate of 3.9% in September 2025 supported public healthcare funding and patient access.
- Retail sales grew modestly by 0.8% year-over-year in September 2025, indicating stable consumer spending.
- Consumer confidence at -23.6 in September 2025 indicated pessimistic sentiment, potentially constraining healthcare.
Why did the price of Metoclopramide HCL change in September 2025 in Europe?
- Producer prices for chemical and pharma declined -1.7% year-over-year in Q3 2025, reducing input costs.
- Elevated chemical raw material costs and strengthened industrial electricity prices increased production expenses.
- German chemical industry overcapacities and weakening export demand created competitive pricing.
